Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2609858 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL24718806 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL23258677 | 0.92 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL2609875 | 0.91 | — | — | |
| SCHEMBL24718805 | 0.91 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL16303039 | 0.90 | ERBB2 (0.30) | KDM4EATML3MBTL1ERBB2CYP1A2 | |
| SCHEMBL25741303 | 0.90 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL2609857 | 0.89 | KDM4E (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL23258678 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL2609837 | 0.86 | KDM4E (0.41) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023190597-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | 出光興産株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11527720-B1 | Organic electroluminescence device, electronic device, and compound | IDEMITSU KOSAN CO., LTD. (JP) | 2022-12-13 | — | — | US | disclosed |
| US-9224961-B2 | Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-29 | — | — | US | disclosed |
| US-9224961-B2 | Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-29 | — | — | US | disclosed |
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | OCIAD1, OCIAD2, CFD | KDM4E 3315/4885ATM 4310/4885L3MBTL1 2477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.